No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans

References

• Shekelle RB, Stamler J. Fish and coronary heart disease: the epidemiologic evidence. Nutr Metab Cardiovasc Dis 1993; 3: 46–51
   Google Scholar
• Bang HO, Dyerberg J, Sinclair HM. The composition of Eskimo food in north-western Greenland. Am J Clin Nutr 1980; 33: 2657–61
   PubMed Web of Science ®Google Scholar
• Bjerregaard P. Disease pattern in Greenland: Studies on morbidity in Upernavik 1979–1980 and mortality in Greenland 1968–1985. Arctic Med Res 1991; 50: 1–62, Suppl 4
   PubMedGoogle Scholar
• Kagawa Y, Nishizawa M, Suzuki M, Miyatake T, Hamamoto T, Goto K, et al. Eicosapolyenoic acids of serum lipids of Japanese Islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitaminol 1982; 28: 441–53
   PubMed Web of Science ®Google Scholar
• Newman WP, Middaugh JP, Propst MT, Rogers DR. Atherosclerosis in Alaska natives and non-natives. Lancet 1993; 341: 1056–7
   PubMed Web of Science ®Google Scholar
• Kromhout D, Bosschieter EB, Coulander CdL. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205–9
   PubMed Web of Science ®Google Scholar
• Shekelle RB, Missell LV, Paul O, Shryock AM, Stamler J. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985; 313: 820
   PubMedGoogle Scholar
• Norell SE, Ahlbom A, Feychting M, Pedersen NL. Fish consumption and mortality from heart disease. Br Med J 1986; 293: 426
   PubMed Web of Science ®Google Scholar
• Gramenzi A, Gentile A, Fasoli M, Negri E, Parazzini F, Vecchia CL. Association between certain foods and risk of acute myocardial infarction in women. Br Med J 1990; 300: 771–3
   PubMed Web of Science ®Google Scholar
• Dolecek TA, Grandits G. Dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial (MRFIT). World Rev Nutr Diet 1991; 66: 205–16
   PubMedGoogle Scholar
• Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet 1989; ii: 757–60
   Google Scholar
• de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin J-L, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454–9
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–9
   PubMed Web of Science ®Google Scholar
• Nordøy A. Is there a rationale use for n-3 fatty acids (fish oils) in clinical medicine?. Drugs 1991; 42: 331–42
   PubMed Web of Science ®Google Scholar
• Schmidt EB, Pedersen JO, Varming K, Ernst E, Jersild C, Grunnet N, et al. n-3 Fatty acids and leucocyte chemotaxis: effects in hyperlipidemia and dose-response studies in healthy males. Arterioscler Thromb 1991; 11: 429–35
   PubMedGoogle Scholar
• Powell WS. High-pressure liquid chromatography in the analysis of arachidonic acid metabolites. Prostaglandins and related substances, C Benedetto, RG McDonald-Gibson, S Nigam, TF Slater. IRL Press, Oxford 1987; 75–98
   Google Scholar
• Lagarde M, Croset M, Véricel E, Calzada C. Effects of small concentrations of eicosapentaenoic acid on platelets. J Intern Med 1989; 225: 177–9, Suppl 1
   Google Scholar
• Winther K, Myrup B, Hølmer G, Høy C-E, Mehlsen J, Schnohr P. Decreased platelet activity without change in fibrìnolytic activity after low dosages of fish oil. Angiology 1993; 8: 39–44
   Google Scholar
• Lervang HH, Schmidt EB, Møller J, Svaneborg N, Vaming K, Madsen PH, et al. The effect of low-dose supplementation with n-3 polyunsaturated fatty acids on some risk markers of coronary heart disease. Scand J Clin Lab Invest 1993; 53: 417–23
   PubMed Web of Science ®Google Scholar
• Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J, Spur BW, et al. Effect of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acids on in vitro neutrophil and mono-cyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312: 1217–24
   PubMed Web of Science ®Google Scholar
• Schmidt EB, Dyerberg J. n-3 Fatty acids and leucocytes. J Intern Med 1989; 225: 151–8, Suppl 1
   Web of Science ®Google Scholar
• Schmidt EB, Pedersen JO, Ekelund S, Grunnet N, Jersild C, Dyerberg J. Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis 1989; 77: 53–7
   PubMed Web of Science ®Google Scholar
• Schmidt EB, Varming K, Pedersen JO, Lervang H-H, Grunnet N, Jersild C, et al. Long-term supplementation with n-3 fatty acids, II: Effect on neutrophil and monocyte chemotaxis. Scand J Clin Lab Invest 1992; 52: 229–36
   PubMed Web of Science ®Google Scholar
• Fisher M, Levine PH, Weiner BH, Johnson MH, Doyle EM, Ellis PA, et al. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am J Clin Nutr 1990; 51: 804–8
   PubMed Web of Science ®Google Scholar
• Hansen J-B, Olsen JO, Wilsgård L, Østerud B. Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J Intern Med 1989; 225: 133–9, Suppl 1
   Web of Science ®Google Scholar
• Tremoli E, Eligini S, Colli S, Maderna P, Risé P, Pazzucconi F, et al. n-3 Fatty acid ethyl ester administration to healthy subjects and to hypertrig-lyceridemic patients reduces tissue factor activity in adherent monocytes. Arterioscler Thromb 1994; 14: 1600–8
   PubMedGoogle Scholar
• Kaminski WE, Jendraschak E, Kiefl R, von Schacky C. Dietary Ω-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood 1993; 81: 1871–9
   PubMed Web of Science ®Google Scholar
• Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JWM, et al. The effect of dietary supplementation with n-3 polyun-saturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mono-nuclear cells. N Engl J Med 1989; 320: 265–71
   PubMed Web of Science ®Google Scholar
• Mølvig J, Pociot F, Worsaa H, Wogensen LD, Baek L, Christensen P, et al. Dietary supplementation with Ω-3 polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 β content but not monokine secretion in healthy and insulin-dependent diabetic individuals. Scand J Immunol 1991; 34: 399–410
   PubMed Web of Science ®Google Scholar
• Endres S, Meydani SN, Ghorbani R, Schindler R, Dinarello CA. Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leuc Biol 1993; 54: 599–603
   PubMed Web of Science ®Google Scholar
• De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA, Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994; 14: 1829–36
   PubMedGoogle Scholar
• Ferrante A, Goh D, Harvey DP, Robinson BS, Hii CST, Bates EJ, et al. Neutrophil migration inhibitory properties of polyunsaturated fatty acids. The role of fatty acid structure, metabolism, and possible second messenger systems. J Clin Invest 1994; 93: 1063–70
   PubMedGoogle Scholar
• Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. Dietary Ω-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 1993; 91: 651–60
   PubMed Web of Science ®Google Scholar
• Meydani SN, Lichtenstein AH, Cornwall S, Meydani M, Goldin BR, Rasmussen H, et al. Immunologic effects of National Cholesterol Education Panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. J Clin Invest 1993; 92: 105–13
   PubMed Web of Science ®Google Scholar